Metabolic Management
|
December 31, 2024

Semaglutide for Weight Loss: Side Effects and Dosage Guide

Written By
Medically Reviewed by
Dr. Ayesha Bryant MSPH, MD
Updated On
January 9, 2025

Losing weight can be a tough journey, and many people look for options to help them along the way. One medication that's been getting a lot of attention recently is Semaglutide

Initially created to help manage type 2 diabetes, Semaglutide has been shown in clinical studies to support weight loss in individuals with specific health profiles, though results may vary. 

If you’ve heard about semaglutide and are wondering if it’s the right choice for you, this article will help. However, it is always important to discuss your options with your healthcare provider. We’ll cover key information you need to know, including how it works, possible side effects, dosage recommendations, and costs. 

[signup]

What is Semaglutide?

Semaglutide was first developed to help individuals with type 2 diabetes manage their blood sugar levels. It was introduced as an injectable medication under the brand names Ozempic and Rybelsus for diabetes management. 

In recent years, researchers discovered that semaglutide also supports significant weight loss when combined with a healthy diet and exercise. As a result, the FDA approved a higher-dose version of semaglutide, sold as Wegovy, specifically for weight loss.

This dual benefit—managing blood sugar while reducing weight—has made semaglutide a popular choice for doctors and patients.

While Wegovy is FDA-approved specifically for weight loss, other semaglutide products like Ozempic and Rybelsus are approved for diabetes management and are not FDA-approved for weight loss.

Consult a healthcare provider to determine if semaglutide is appropriate for your health profile.

How It Works

Semaglutide belongs to a class of medications called GLP-1 receptor agonists (glucagon-like peptide-1). GLP-1 is a natural hormone that helps regulate appetite and blood sugar. When you take semaglutide, it mimics this hormone, resulting in several effects:

Appetite suppression

Research suggests semaglutide supports appetite suppression by reducing hunger and increasing feelings of fullness and satiety after meals. This may help individuals manage their food intake more effectively by improving their control of eating and reducing food cravings.

Blood sugar control

Research suggests that semaglutide supports blood sugar control by stimulating insulin secretion in response to meals while reducing glucagon's release, a hormone that raises blood sugar levels. These combined effects help promote balanced blood sugar levels in individuals with type 2 diabetes.

Weight reduction

Research from the SELECT trial suggests that semaglutide supports long-term weight loss by modulating appetite through its effects on glucagon-like peptide-1 (GLP-1) receptors, which influence hunger signals in the brain. This action, sustained over 4 years, resulted in an average weight reduction of 10.2% compared to 1.5% with placebo, alongside improvements in waist circumference and body fat distribution.

Semaglutide for Weight Loss

Semaglutide has gained significant attention for its ability to aid weight loss. Let’s examine the evidence behind its effectiveness, the recommended dosages, and real-life success stories.

Clinical Trials and Efficacy

Extensive research has shown that semaglutide supports weight loss in adults with obesity or those who are overweight with related health issues. In clinical trials, participants who took semaglutide and lifestyle changes lost an average of 14–17% of their body weight over 68 weeks.

One notable study published in The New England Journal of Medicine (2021) demonstrated that participants taking semaglutide lost significantly more weight than those taking a placebo. These results confirm that semaglutide can be a valuable option for individuals struggling to lose weight through diet and exercise alone.

These results were observed in clinical study settings. Individual results may vary based on diet, exercise, and overall health.

Recommended Dosage

Semaglutide for weight loss is taken as a once-weekly injection. It’s important to start with a low dose and gradually increase it to minimize side effects like nausea or upset stomach.

Here’s a typical titration schedule for Wegovy (semaglutide for weight loss):

  • Week 1–4: 0.25 mg once a week
  • Week 5–8: 0.5 mg once a week
  • Week 9–12: 1.0 mg once a week
  • Week 13–16: 1.7 mg once a week
  • Week 17 and beyond: 2.4 mg once a week (maintenance dose)

The slow increase allows your body to adjust to the medication. Your doctor will determine the best schedule for you, as individual needs may vary. For more detailed guidance, consult the FDA-approved prescribing information for Wegovy. Always follow your healthcare provider’s instructions regarding dose adjustments.

Side Effects of Semaglutide

Like all medications, semaglutide can cause side effects. While many people tolerate it well, it’s important to understand the potential risks to use it safely. 

Common Side Effects

Most side effects with semaglutide are mild and tend to improve as your body adjusts to the medication. Common side effects include:

  • Nausea: This is the most frequently reported side effect, especially when starting or increasing the dose. Eating smaller meals and avoiding greasy or spicy foods may help.
  • Diarrhea or constipation: Some people experience changes in digestion. Staying hydrated and eating high-fiber foods can ease symptoms.
  • Headache: Occasional headaches may occur as your body gets used to the medication.
  • Fatigue or dizziness: These symptoms are less common but can happen, particularly at higher doses.

Studies show that these side effects lessen over time and may be reduced by following the recommended dose escalation schedule. This list of side effects is not exhaustive. For a comprehensive list, consult the FDA-approved prescribing information or speak to your pharmacist or doctor.

Individual experiences can vary; some may not experience side effects.

Severe Side Effects

Although rare, semaglutide may cause more serious side effects in some individuals. Here’s what to watch for:

  • Pancreatitis (inflammation of the pancreas): Symptoms may include severe stomach pain, nausea, and vomiting. If you experience these, stop taking the medication and contact your doctor immediately.
  • Thyroid tumors or cancer: In animal studies, semaglutide causes thyroid tumors, but the risk in humans is still unclear. A 2023 systematic review and meta-analysis found no causal link between semaglutide and thyroid cancer in humans. The medication is not recommended for individuals with a family history of certain types of thyroid cancer (e.g., medullary thyroid carcinoma).
  • Gallbladder issues: Semaglutide may slightly increase the risk of gallstones or gallbladder inflammation, which can cause abdominal pain and other symptoms.
  • Allergic reactions: In rare cases, semaglutide may cause swelling, rash, or difficulty breathing. Seek emergency care if this happens.

Patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2) should avoid semaglutide, as per FDA guidelines.

Safety Tips

To minimize risks and use semaglutide safely, follow these guidelines:

  • Start with a low-dose
  • Avoid if contraindicated
  • Tell your doctor about other medications you’re taking.
  • Follow dietary recommendations

Knowing the potential risks and how to manage them can help ensure a positive experience with semaglutide.

Cost and Accessibility of Semaglutide

Semaglutide can be a powerful tool for weight loss and blood sugar management, but it comes with a price tag. Let’s break down the costs and explore ways to make it more affordable.

Retail Pricing

The cost of semaglutide depends on the brand and dosage:

  • Wegovy (weight loss): About $1350 to $2000 per month without insurance.
  • Ozempic (diabetes): Priced at $900 to $1,100 per month.
  • Rybelsus (oral version for diabetes): Also priced at approximately $1000 per month.

Prices may vary by location, pharmacy, and insurance plan. These figures are approximate and subject to change. 

Insurance Coverage

Insurance coverage for semaglutide depends on whether you’re prescribed the medication for diabetes or weight loss. Insurance approval often depends on medical necessity and documented obesity-related health issues.

To navigate insurance:

  • Check your benefits: Call your provider to confirm if semaglutide is covered and what your co-pay would be.
  • Ask your doctor for prior authorization: Some insurance companies require this before approving coverage.
  • Appeal denials: If your insurance denies coverage, you can appeal the decision with supporting documentation from your doctor.

Cost-Saving Strategies

If semaglutide feels out of reach financially, here are some options to reduce the cost:

  • Manufacturer discounts: Companies like Novo Nordisk, the maker of Wegovy and Ozempic, offer savings cards for eligible patients. These cards can significantly lower out-of-pocket costs.
  • Patient assistance programs: Novo Nordisk also has programs for low-income patients who qualify for free or discounted medications.
  • Pharmacy discounts: Websites like GoodRx can help you find lower prices or coupons for semaglutide at local pharmacies.

Eligibility for discounts and patient assistance programs varies; check specific program requirements for up-to-date information. By exploring these strategies, you may be able to access semaglutide at a price that works for your budget.

Administering Semaglutide

Administering semaglutide is straightforward, but learning the correct technique is crucial to ensuring the medication works effectively and safely. In this chapter, we’ll explain how to inject semaglutide, how to store it properly, and tips for handling it with care.

Injection Technique

Semaglutide is injected under the skin (subcutaneously) using a prefilled pen. Here’s a step-by-step guide for proper administration:

  1. Choose an injection site:
    • Common injection sites include the abdomen (at least 2 inches away from the belly button), the front of the thigh, or the upper arm. Rotate the site with each injection to avoid irritation.
  2. Prepare the pen:
    • Check the pen’s expiration date and make sure the medication is clear and colorless (not cloudy).
    • Attach a new needle to the pen. Remove the outer and inner caps from the needle.
  3. Prime the pen (if necessary):
    • For first-time use, you may need to remove air bubbles by priming the pen. Follow the instructions that come with your pen to do this.
  4. Inject the medication:
    • Pinch a small section of skin at the chosen site.
    • Insert the needle at a 90-degree angle and press the button to release the medication.
    • Hold the pen in place for 10 seconds to ensure the full dose is delivered.
  5. Dispose of the needle:
    • Safely discard the used needle in a sharps container. Never reuse needles.

Always follow the instructions in the official medication guide for your specific pen device, and consult a healthcare provider for a demonstration if you’re new to injections. If you have any concerns about the injection technique, contact your healthcare professional.

Storage and Handling

Proper storage of semaglutide is essential to maintain its effectiveness. Here are a few tips:

  • Keep refrigerated: Store unused pens in the refrigerator (36–46°F). Avoid freezing, as this can damage the medication.
  • Room temperature use: After opening, semaglutide pens can be stored at room temperature (up to 86°F) for up to 28 days.
  • Protect from light: Keep the pen in its original box to shield it from light when not in use.
  • Avoid shaking: Do not shake the pen, which may reduce the medication’s potency.

If you’re unsure about storage or handling, consult the medication guide or ask your pharmacist for clarification.

[signup]

Key Takeaways

  • Semaglutide supports weight loss by reducing appetite and stabilizing blood sugar levels. Clinical trials show significant results when combined with healthy lifestyle changes.
  • Common side effects include nausea, diarrhea, and fatigue, but most are temporary. Rare risks include pancreatitis and thyroid issues.
  • It’s important to follow a gradual titration schedule, starting with a low dose and increasing over time to minimize side effects.
  • While semaglutide can be expensive, assistance programs, manufacturer discounts, and insurance coverage may help make it more affordable.
  • Proper injection technique and storage are vital to ensure the medication works effectively and safely.
  • If you’re interested in semaglutide, consult your healthcare provider for personalized advice. They can help determine whether this medication is right for you and guide you through the process of starting and maintaining treatment.
The information in this article is designed for educational purposes only and is not intended to be a substitute for informed medical advice or care. This information should not be used to diagnose or treat any health problems or illnesses without consulting a doctor. Consult with a health care practitioner before relying on any information in this article or on this website.

Learn more

No items found.

Lab Tests in This Article

No lab tests!

Bergmann, N. C., Davies, M. J., Lingvay, I., & Knop, F. K. (2022). Semaglutide for the treatment of overweight and obesity: A review. Diabetes, Obesity and Metabolism, 25(1). https://doi.org/10.1111/dom.14863

Billingsley, A. (2023, April 4). Is There a Best Place to Inject Ozempic? GoodRx; GoodRx. https://www.goodrx.com/ozempic/where-to-inject-ozempic

Chao, A. M., Tronieri, J. S., Amaro, A., & Wadden, T. A. (2021). Semaglutide for the treatment of obesity. Trends in Cardiovascular Medicine, 33(3). https://doi.org/10.1016/j.tcm.2021.12.008

Chao, A. M., Tronieri, J. S., Amaro, A., & Wadden, T. A. (2022). Clinical Insight on Semaglutide for Chronic Weight Management in Adults: Patient Selection and Special Considerations. Drug Design, Development and Therapy, Volume 16, 4449–4461. https://doi.org/10.2147/dddt.s365416

Cleveland Clinic. (2024). Semaglutide injection. Cleveland Clinic. https://my.clevelandclinic.org/health/drugs/19011-semaglutide-injection

Cloyd, J. (2023, July 5). Integrative Approaches to Managing High Blood Sugar: Specialty Testing, Lifestyle Modifications, and Natural Remedies. Rupa Health. https://www.rupahealth.com/post/integrative-approaches-to-managing-high-blood-sugar-testing-lifestyle-modifications-and-natural-remedies

Collins, L., & Costello, R. A. (2024, February 29). Glucagon-like peptide-1 receptor agonists. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK551568/

Does Insurance Cover Prescription Weight Loss Injectables? (2024). NAIC. https://content.naic.org/article/does-insurance-cover-prescription-weight-loss-injectables

FDA. (2021, June 4). FDA Approves New Drug Treatment for Chronic Weight Management, First Since 2014. FDA. https://www.fda.gov/news-events/press-announcements/fda-approves-new-drug-treatment-chronic-weight-management-first-2014

Fornes, A., Huff, J., Pritchard, R. I., & Godfrey, M. (2022). Once-Weekly Semaglutide for Weight Management: A Clinical Review. Journal of Pharmacy Technology, 38(4), 875512252210926. https://doi.org/10.1177/87551225221092681

Friedrichsen, M., Breitschaft, A., Tadayon, S., Wizert, A., & Skovgaard, D. (2021). The effect of semaglutide 2.4 mg once weekly on energy intake, appetite, control of eating, and gastric emptying in adults with obesity. Diabetes, Obesity and Metabolism, 23(3), 754–762. https://doi.org/10.1111/dom.14280

Ghusn, W., De la Rosa, A., Sacoto, D., Cifuentes, L., Campos, A., Feris, F., Hurtado, M. D., & Acosta, A. (2022). Weight Loss Outcomes Associated With Semaglutide Treatment for Patients With Overweight or Obesity. JAMA Network Open, 5(9), e2231982. https://doi.org/10.1001/jamanetworkopen.2022.31982

He, L., Wang, J., Ping, F., Yang, N., Huang, J., Li, Y., Xu, L., Li, W., & Zhang, H. (2022). Association of Glucagon-Like Peptide-1 Receptor Agonist Use With Risk of Gallbladder and Biliary Diseases. JAMA Internal Medicine, 182(5). https://doi.org/10.1001/jamainternmed.2022.0338

HIGHLIGHTS OF PRESCRIBING INFORMATION. (n.d.). https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215256s007lbl.pdf

How Much Will New Weight Loss Drug Wegovy Cost? - GoodRx. (n.d.). GoodRx. https://www.goodrx.com/wegovy/wegovy-for-weight-loss-cost-coverage

Kooij, K. L., Koster, D. Ij., Eeltink, E., Luijendijk, M., Drost, L., Ducrocq, F., & Adan, R. A. H. (2023). GLP-1 receptor agonist semaglutide reduces appetite while increasing dopamine reward signaling. Neuroscience Applied, 103925. https://doi.org/10.1016/j.nsa.2023.103925

Mahapatra, M. K., Karuppasamy, M., & Sahoo, B. M. (2022). Semaglutide, a glucagon like peptide-1 receptor agonist with cardiovascular benefits for management of type 2 diabetes. Reviews in Endocrine and Metabolic Disorders, 23(3). https://doi.org/10.1007/s11154-021-09699-1

Maholy, N. (2023, March 9). Integrative Medicine Protocol For Reversing Type 2 Diabetes. Rupa Health. https://www.rupahealth.com/post/integrative-medicine-protocol-for-reversing-type-2-diabetes

MedlinePlus. (2022, August 15). Semaglutide injection: MedlinePlus drug information. Medlineplus.gov. https://medlineplus.gov/druginfo/meds/a618008.html

Medullary Thyroid Cancer - National Cancer Institute. (2019, February 27). Www.cancer.gov. https://www.cancer.gov/pediatric-adult-rare-tumor/rare-tumors/rare-endocrine-tumor/medullary-thyroid-cancer

Miles, K. E., & Kerr, J. L. (2018). Semaglutide for the Treatment of Type 2 Diabetes Mellitus. Journal of Pharmacy Technology, 34(6), 281–289. https://doi.org/10.1177/8755122518790925

Nagendra, L., Bg, H., Sharma, M., & Dutta, D. (2023). Semaglutide and cancer: A systematic review and meta-analysis. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 17(9), 102834. https://doi.org/10.1016/j.dsx.2023.102834

Neibling, K. (2023, February 27). Integrative medicine treatment for headaches. Rupa Health. https://www.rupahealth.com/post/integrative-medicine-treatment-for-headaches

Novo Nordisk Patient Assistance Program (PAP) | NovoCare®. (n.d.). Www.novocare.com. https://www.novocare.com/diabetes/help-with-costs/pap.html

Official Site | RYBELSUS® (semaglutide) tablets 7 mg or 14 mg. (n.d.). Www.rybelsus.com. https://www.rybelsus.com/

Okamoto, A., Yokokawa, H., Nagamine, T., Fukuda, H., Hisaoka, T., & Naito, T. (2021). Efficacy and safety of semaglutide in glycemic control, body weight management, lipid profiles and other biomarkers among obese type 2 diabetes patients initiated or switched to semaglutide from other GLP-1 receptor agonists. Journal of Diabetes & Metabolic Disorders. https://doi.org/10.1007/s40200-021-00899-9

Ozempic. (2024, February). Ozempic® Once Weekly Non-Insulin | Ozempic® (semaglutide) injection 0.5 mg or 1 mg. Www.ozempic.com. https://www.ozempic.com/

Ozempic Prices, Coupons & Patient Assistance Programs. (n.d.). Drugs.com. https://www.drugs.com/price-guide/ozempic

Ozempic® (semaglutide) injection 0.5mg, 1 mg, or 2 mg Savings Offer | NovoCare®. (n.d.). Www.novocare.com. https://www.novocare.com/diabetes/products/ozempic/savings-offer.html

Patel, F., Gan, A., Chang, K., & Vega, K. J. (2023). Acute Pancreatitis in a Patient Taking Semaglutide. Cureus, 15(8), e43773. https://doi.org/10.7759/cureus.43773

Ryan, D. H., Lingvay, I., Deanfield, J., Kahn, S. E., Barros, E., Burguera, B., Colhoun, H. M., Cercato, C., Dicker, D., Horn, D. B., Hovingh, G. K., Jeppesen, O. K., Kokkinos, A., Lincoff, A. M., Meyhöfer, S. M., Oral, T. K., Plutzky, J., van Beek, A. P., Wilding, J. P. H., & Kushner, R. F. (2024). Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial. Nature Medicine, 30, 1–9. https://doi.org/10.1038/s41591-024-02996-7

Rybelsus Prices, Coupons, Copay & Patient Assistance. (n.d.). Drugs.com. https://www.drugs.com/price-guide/rybelsus

Shu, Y., He, X., Wu, P., Liu, Y., Ding, Y., & Zhang, Q. (2022). Gastrointestinal adverse events associated with semaglutide: A pharmacovigilance study based on FDA adverse event reporting system. Frontiers in Public Health, 10. https://doi.org/10.3389/fpubh.2022.996179

Singh, G., Krauthamer, M., & Bjalme-Evans, M. (2021). Wegovy (semaglutide): a new weight loss drug for chronic weight management. Journal of Investigative Medicine, 70(1), jim-2021-001952. https://doi.org/10.1136/jim-2021-001952

Sweetnich, J. (2023, April 25). Complementary and Integrative Medicine Approaches to Type 2 Diabetes Management. Rupa Health. https://www.rupahealth.com/post/complementary-and-integrative-medicine-approaches-to-type-2-diabetes-management

Wegovy Prices, Coupons & Savings Tips. (n.d.). GoodRx. https://www.goodrx.com/wegovy

Wegovy® (semaglutide) injection 2.4 mg List Price & Insurance Coverage Explained | NovoCare®. (n.d.). Www.novocare.com. https://www.novocare.com/obesity/products/wegovy/let-us-help/explaining-list-price.html

Wegovy® Dosing Schedule | Wegovy® (semaglutide) Injection 2.4 mg. (n.d.). Www.wegovy.com. https://www.wegovy.com/taking-wegovy/dosing-schedule.html

Wilding, J. P. H., Batterham, R. L., & Calanna, S. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. The New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183

Zheng, Z., Zong, Y., Ma, Y., Tian, Y., Pang, Y., Zhang, C., & Gao, J. (2024). Glucagon-like peptide-1 receptor: mechanisms and advances in therapy. Signal Transduction and Targeted Therapy, 9(1), 1–29. https://doi.org/10.1038/s41392-024-01931-z

Order from 30+ labs in 20 seconds (DUTCH, Mosaic, Genova & More!)
We make ordering quick and painless — and best of all, it's free for practitioners.

Latest Articles

View more on Metabolic Management
Subscribe to the magazine for expert-written articles straight to your inbox
Join the thousands of savvy readers who get root cause medicine articles written by doctors in their inbox every week!
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Subscribe to the Magazine for free to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Trusted Source
Rupa Health
Medical Education Platform
Visit Source
Visit Source
American Cancer Society
Foundation for Cancer Research
Visit Source
Visit Source
National Library of Medicine
Government Authority
Visit Source
Visit Source
Journal of The American College of Radiology
Peer Reviewed Journal
Visit Source
Visit Source
National Cancer Institute
Government Authority
Visit Source
Visit Source
World Health Organization (WHO)
Government Authority
Visit Source
Visit Source
The Journal of Pediatrics
Peer Reviewed Journal
Visit Source
Visit Source
CDC
Government Authority
Visit Source
Visit Source
Office of Dietary Supplements
Government Authority
Visit Source
Visit Source
National Heart Lung and Blood Institute
Government Authority
Visit Source
Visit Source
National Institutes of Health
Government Authority
Visit Source
Visit Source
Clinical Infectious Diseases
Peer Reviewed Journal
Visit Source
Visit Source
Brain
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Rheumatology
Peer Reviewed Journal
Visit Source
Visit Source
Journal of the National Cancer Institute (JNCI)
Peer Reviewed Journal
Visit Source
Visit Source
Journal of Cardiovascular Magnetic Resonance
Peer Reviewed Journal
Visit Source
Visit Source
Hepatology
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Clinical Nutrition
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Bone and Joint Surgery
Peer Reviewed Journal
Visit Source
Visit Source
Kidney International
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Allergy and Clinical Immunology
Peer Reviewed Journal
Visit Source
Visit Source
Annals of Surgery
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Neurology, Neurosurgery & Psychiatry
Peer Reviewed Journal
Visit Source
Visit Source
Chest
Peer Reviewed Journal
Visit Source
Visit Source
Blood
Peer Reviewed Journal
Visit Source
Visit Source
Gastroenterology
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Respiratory and Critical Care Medicine
Peer Reviewed Journal
Visit Source
Visit Source
The American Journal of Psychiatry
Peer Reviewed Journal
Visit Source
Visit Source
Diabetes Care
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of the American College of Cardiology (JACC)
Peer Reviewed Journal
Visit Source
Visit Source
The Journal of Clinical Oncology (JCO)
Peer Reviewed Journal
Visit Source
Visit Source
Journal of Clinical Investigation (JCI)
Peer Reviewed Journal
Visit Source
Visit Source
Circulation
Peer Reviewed Journal
Visit Source
Visit Source
JAMA Internal Medicine
Peer Reviewed Journal
Visit Source
Visit Source
PLOS Medicine
Peer Reviewed Journal
Visit Source
Visit Source
Annals of Internal Medicine
Peer Reviewed Journal
Visit Source
Visit Source
Nature Medicine
Peer Reviewed Journal
Visit Source
Visit Source
The BMJ (British Medical Journal)
Peer Reviewed Journal
Visit Source
Visit Source
The Lancet
Peer Reviewed Journal
Visit Source
Visit Source
Journal of the American Medical Association (JAMA)
Peer Reviewed Journal
Visit Source
Visit Source
Pubmed
Comprehensive biomedical database
Visit Source
Visit Source
Harvard
Educational/Medical Institution
Visit Source
Visit Source
Cleveland Clinic
Educational/Medical Institution
Visit Source
Visit Source
Mayo Clinic
Educational/Medical Institution
Visit Source
Visit Source
The New England Journal of Medicine (NEJM)
Peer Reviewed Journal
Visit Source
Visit Source
Johns Hopkins
Educational/Medical Institution
Visit Source
Visit Source

Hey practitioners! 👋 Join Dr. Chris Magryta and Dr. Erik Lundquist for a comprehensive 6-week course on evaluating functional medicine labs from two perspectives: adult and pediatric. In this course, you’ll explore the convergence of lab results across different diseases and age groups, understanding how human lab values vary on a continuum influenced by age, genetics, and time. Register Here! Register Here.